[ad_1]
The Aegean University has given scientists the end of long-term lung cancer trials. Scientists are prototypes that do not damage saline cells when treating Akcier's cancer
has developed a product.
Scientists at Ege University have developed a prototype product that can treat these diseases without harming blood cells during treatment due to long-term cancer. prot TQGMNP ok was the name of the prototype developed using the bioactive substance called otip Timokinon P, located in the seeds of the herbaceous plant. As a result of 2 years of use, & # 39; TQGMNP & # 39; has been named patent. Dr. Rektr Dr. Necdet Budak, about the prototype. Gr. Dr. felicity taking information from nce. Rektr Budak, who took note of the signatures of academicians in the field of wet reception, said, deki Our reception group at the Aegean University Institute of Science prepared a preparation for the treatment and treatment of cancer. and I followed one another to win the name of humanity.
Dr. nce, "This is a prototype that does not harm salkl cells during treatment because of lung cancer.To do this, we need investors, as Rektr hocamzn said," did he declares.
[ad_2]
Source link
